Published on November 4, 2026 Medicine – Eosinophilia Eosinophils are granulocytes involved in allergic reactions, defence against certain parasitic infections and immune-mediated inflammation. The major causes of eosinophilia include allergic disorders, helminthic infections, skin diseases, connective tissue disorders and neoplasms. 1. Classification of Eosinophilia Severity Absolute eosinophil count (AEC) Mild 0.5–1.5 × 10⁹/L Moderate 1.5–5.0 × 10⁹/L Severe Above 5.0 × 10⁹/L Hypereosinophilia is generally defined as an AEC of at least 1.5 × 10⁹/L, particularly when persistent. Hypereosinophilic syndrome refers to hypereosinophilia associated with eosinophil-mediated organ damage, after appropriate evaluation. 2. Pathophysiology Eosinophilia results from increased production, activation or survival of eosinophils, often mediated by cytokines such as interleukin-5 (IL-5). Eosinophils contain cytotoxic granule proteins, including major basic protein and eosinophil cationic protein. Excessive activation can damage tissues, particularly the heart, lungs, skin, gastrointestinal tract and nervous system. 3. Causes of Eosinophilia A. Allergic Disorders Allergic diseases are common causes of mild eosinophilia. They are associated with type 2 immune responses involving IL-4, IL-5 and IL-13. 1. Asthma Eosinophilia may occur in eosinophilic or allergic asthma. Associated findings include: * Episodic wheezing. * Breathlessness. * Chest tightness. * Cough, particularly at night or early morning. * Reversible airflow obstruction. Peripheral eosinophilia may support an eosinophilic asthma phenotype but is not diagnostic on its own. 2. Hay Fever (Allergic Rhinitis) Hay fever is an IgE-associated allergic disorder affecting the nasal mucosa. Typical features include: * Sneezing. * Watery rhinorrhoea. * Nasal itching. * Nasal congestion. * Itchy or watery eyes. Eosinophilia may accompany allergic rhinitis, although many patients have normal circulating eosinophil counts. 3. Drug Hypersensitivity Drug hypersensitivity reactions may produce eosinophilia. Important implicated medications include certain antibiotics, anticonvulsants and allopurinol. Clinical manifestations range from mild rashes to severe systemic reactions. Drug reaction with eosinophilia and systemic symptoms (DRESS) is an important potentially life-threatening condition characterised by a drug-associated eruption, fever and possible internal organ involvement. Eosinophilia is common but may be absent early. Clinical warning Eosinophilia associated with a new medication, widespread rash, fever, facial swelling, lymphadenopathy or abnormal liver function should prompt urgent assessment for a severe drug hypersensitivity reaction. B. Parasitic Infections – Helminths Helminthic infections are important causes of eosinophilia, especially parasites with a tissue-invasive phase. Eosinophils contribute to host defence against helminths through antibody-dependent mechanisms and release of cytotoxic granule proteins. 1. Ascariasis Ascariasis is caused by Ascaris lumbricoides. During larval migration through the lungs, patients may develop: * Cough. * Wheezing. * Transient pulmonary infiltrates. * Peripheral eosinophilia. This pulmonary manifestation may be referred to as Löffler’s syndrome. Intestinal infection may cause abdominal discomfort, malnutrition or intestinal obstruction in heavy infections. 2. Schistosomiasis Schistosomiasis is caused by Schistosoma species. Eosinophilia is particularly associated with acute infection and larval or early tissue migration. Clinical manifestations vary by species and may include: * Fever. * Abdominal pain. * Diarrhoea. * Hepatosplenomegaly. * Haematuria in urinary schistosomiasis. Acute schistosomiasis may present as Katayama syndrome, with fever, systemic symptoms and marked eosinophilia. Other Important Helminthic Causes * Strongyloidiasis. * Hookworm infection. * Filariasis. * Toxocariasis. * Trichinellosis. Important clinical pearl: In patients with relevant epidemiological exposure, Strongyloides stercoralis infection should be considered before administering systemic corticosteroids because immunosuppression can precipitate life-threatening hyperinfection. C. Skin Diseases Certain inflammatory skin disorders are associated with eosinophilia. 1. Eczema (Atopic Dermatitis) Atopic dermatitis is a chronic inflammatory skin disease associated with type 2 immune activation. Typical features include: * Pruritus. * Dry skin. * Erythematous eczematous lesions. * Lichenification in chronic disease. * Flexural involvement in many older children and adults. Peripheral eosinophilia may be present, particularly in more severe atopic disease. 2. Dermatitis Herpetiformis Dermatitis herpetiformis is an autoimmune blistering skin disorder strongly associated with gluten-sensitive enteropathy (coeliac disease). Typical findings include: * Intensely pruritic grouped papules and vesicles. * Lesions on extensor surfaces, including elbows, knees and buttocks. * Granular IgA deposition in dermal papillae on direct immunofluorescence. Eosinophils may be present in skin lesions, but peripheral blood eosinophilia is not a defining or consistently present feature of dermatitis herpetiformis. 4. Connective Tissue and Inflammatory Disorders A. Rheumatoid Arthritis (RA) Rheumatoid arthritis is a chronic autoimmune inflammatory disorder affecting synovial joints. Mild eosinophilia may occur, particularly in association with severe disease, extra-articular manifestations, coexisting atopy or medication reactions. However, eosinophilia is not a characteristic diagnostic feature of uncomplicated RA. B. Churg–Strauss Syndrome Churg–Strauss syndrome, now termed eosinophilic granulomatosis with polyangiitis (EGPA), is a systemic eosinophilic inflammatory disease associated with small- to medium-vessel vasculitis. It is strongly associated with asthma and eosinophilia. Characteristic Features * Adult-onset asthma. * Chronic rhinosinusitis. * Nasal polyps. * Peripheral eosinophilia, sometimes marked. * Pulmonary infiltrates. * Peripheral neuropathy, including mononeuritis multiplex. * Purpura or other vasculitic skin lesions. * Possible cardiac involvement. ANCA is present in only a subset of patients, commonly with an MPO-ANCA pattern. Classic EGPA Clinical Pattern Asthma Eosinophilia Systemic vasculitis Examination pearl: Asthma with marked eosinophilia, sinus disease and mononeuritis multiplex strongly suggests EGPA. C. Sarcoidosis Sarcoidosis is a multisystem granulomatous inflammatory disease characterised by non-caseating granulomas. Common manifestations include: * Bilateral hilar lymphadenopathy. * Pulmonary infiltrates. * Erythema nodosum. * Uveitis. * Constitutional symptoms. Mild peripheral eosinophilia may occur in some patients, but it is not a typical or defining feature. Marked eosinophilia should prompt investigation for an alternative or additional cause. 5. Neoplasms Eosinophilia may occur in association with malignancy through tumour-derived cytokines or clonal disorders affecting the eosinophil lineage. A. Hodgkin Lymphoma Hodgkin lymphoma may be associated with reactive eosinophilia due to cytokines produced within the tumour microenvironment. Typical clinical features include: * Painless lymphadenopathy. * Fever. * Night sweats. * Unintentional weight loss. * Pruritus. Peripheral eosinophilia is a recognised but nonspecific finding. B. Non-Hodgkin Lymphoma Certain non-Hodgkin lymphomas, particularly some T-cell lymphomas, may cause eosinophilia through cytokine-mediated mechanisms. Clinical manifestations may include lymphadenopathy, constitutional symptoms and organ involvement. C. Other Haematological Neoplasms Persistent marked eosinophilia may also be associated with clonal myeloid neoplasms, including disorders with rearrangements involving PDGFRA, PDGFRB, FGFR1 or other tyrosine kinase genes. These conditions are particularly important when eosinophilia is unexplained, persistent or accompanied by abnormal blood counts or organ involvement. 6. Clinical Features of Eosinophilia Many patients with mild eosinophilia are asymptomatic. Symptoms depend on the underlying disease and whether eosinophil-mediated organ damage is present. Clinical feature Possible cause Wheezing, breathlessness Asthma, EGPA Sneezing, rhinorrhoea Allergic rhinitis Pruritic rash Atopy, drug reaction, skin disease Abdominal symptoms Helminthic infection Fever and rash after medication Drug hypersensitivity or DRESS Pulmonary infiltrates Helminth migration, EGPA Peripheral neuropathy EGPA Lymphadenopathy and B symptoms Lymphoma Chest pain or heart failure Possible eosinophilic cardiac involvement 7. Investigations A. Full Blood Count and Differential Confirm the absolute eosinophil count rather than relying solely on the eosinophil percentage. The absolute eosinophil count is calculated as: \text{AEC}=\text{Total WBC}\times\frac{\%\text{Eosinophils}}{100} B. Peripheral Blood Film Assess eosinophil morphology and look for abnormal or immature cells that may suggest a haematological disorder. C. History and Clinical Examination Important areas include: * Asthma, allergic rhinitis and eczema. * New medications and supplements. * Travel history and exposure to helminths. * Gastrointestinal or respiratory symptoms. * Skin rashes. * Lymphadenopathy. * Neurological symptoms. * Features of connective tissue disease. D. Targeted Investigations Investigation Clinical indication Stool examination for ova and parasites Suspected intestinal helminth infection Parasite serology Selected tissue-invasive helminths, including Strongyloides Serum IgE May support atopic or parasitic causes; nonspecific Renal and liver function Assess systemic involvement ESR and CRP Inflammatory disorders ANCA Suspected EGPA, recognising limited sensitivity Chest imaging Respiratory symptoms or suspected pulmonary involvement ECG, troponin, echocardiography Suspected cardiac involvement Bone marrow and molecular testing Persistent unexplained or suspected clonal eosinophilia Lymph node biopsy Suspicious lymphadenopathy A single negative stool examination does not reliably exclude all helminthic infections, particularly strongyloidiasis. 8. Diagnostic Approach 9. Management Treatment is directed at the underlying cause. Cause General management Asthma Inhaled corticosteroid-based treatment and phenotype-directed therapy Allergic rhinitis Intranasal corticosteroids and antihistamines Drug hypersensitivity Discontinue the suspected drug and assess severity Ascariasis Appropriate anthelmintic treatment Schistosomiasis Praziquantel according to infection stage and clinical guidance Eczema Emollients and anti-inflammatory skin treatment Dermatitis herpetiformis Gluten-free diet; dapsone when appropriate Rheumatoid arthritis Disease-modifying treatment of underlying RA EGPA Specialist-directed glucocorticoids and immunosuppressive or biologic therapy Sarcoidosis Observation or immunosuppressive treatment depending on organ involvement Lymphoma Disease-specific oncological treatment Clonal eosinophilic neoplasm Molecularly guided haematological treatment Patients with hypereosinophilia and suspected cardiac, neurological or other organ involvement require prompt specialist assessment. 10. High-Yield Examination Summary Cause Characteristic association Asthma Allergic or eosinophilic airway inflammation Hay fever Allergic rhinitis Drug hypersensitivity Rash, fever and possible systemic involvement Ascariasis Löffler’s syndrome during pulmonary migration Schistosomiasis Acute helminth infection; Katayama syndrome Eczema Atopic dermatitis Dermatitis herpetiformis Coeliac disease, granular IgA in skin Rheumatoid arthritis Occasionally associated with mild eosinophilia Churg–Strauss syndrome (EGPA) Asthma, eosinophilia and systemic vasculitis Sarcoidosis Possible mild eosinophilia; not a defining feature Hodgkin lymphoma Lymphadenopathy, B symptoms, possible eosinophilia Other lymphomas Cytokine-mediated eosinophilia, especially some T-cell lymphomas 11. Key Examination Pearls * Eosinophilia is generally defined as an AEC above 0.5 × 10⁹/L. * Allergic diseases commonly cause mild eosinophilia. * Helminths with tissue migration are particularly associated with eosinophilia. * Ascariasis may cause transient pulmonary infiltrates and eosinophilia, known as Löffler’s syndrome. * Acute schistosomiasis may produce fever and marked eosinophilia. * Drug hypersensitivity may cause severe systemic illness, including DRESS. * Asthma with eosinophilia, sinus disease and neuropathy strongly suggests EGPA. * Eosinophilia may occur in Hodgkin lymphoma and some other lymphomas. * Persistent hypereosinophilia requires assessment for organ damage and possible clonal disease. * Strongyloidiasis must be considered before systemic corticosteroid treatment in patients with relevant exposure. Most important examination point: Eosinophilia with asthma and allergic rhinitis suggests atopy; eosinophilia with travel or helminth exposure suggests parasitic infection; eosinophilia with asthma, sinusitis and mononeuritis multiplex suggests EGPA; and eosinophilia with painless lymphadenopathy and B symptoms raises suspicion for lymphoma. — Kembara Xtra – Medicine Revision Notes Medicine